Chinook Therapeutics Inc Cvr (ADRO)
Operating Cash Flow (Statement)
-$48.15M
TTM · Period ending: · USD
ADRO Operating Cash Flow (Statement)
Latest reported-$48.15Mperiod ending
Latest reported-$48.15Mperiod ending
ADRO TTM Cash from Operations ($19.37M → -$48.15M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ADRO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -48,145,000 | |
| -66,746,000 | |
| -62,164,000 | |
| -65,508,000 | |
| -44,532,000 | |
| -51,399,000 | |
| -59,367,000 | |
| -68,759,000 | |
| -91,962,000 | |
| -89,690,000 | |
| -86,615,000 | |
| -88,856,000 | |
| -90,086,000 | |
| -104,298,000 | |
| -85,555,000 | |
| -86,076,000 | |
| -63,494,000 | |
| -44,805,000 | |
| 139,918,000 | |
| 154,810,000 | |
| 182,875,000 | |
| 189,129,000 | |
| 15,868,000 | |
| 19,365,000 |